Nanette Que-Gewirth

Title: Nanette Que-Gewirth: Innovator in Platelet Inhibition

Introduction

Nanette Que-Gewirth is a prominent inventor based in Durham, NC (US). She has made significant contributions to the field of medical science, particularly in the area of platelet aggregation and inhibition. With a total of 2 patents, her work has the potential to impact various therapeutic approaches.

Latest Patents

Her latest patents focus on reversible platelet inhibition. The inventions relate to receptors and platelet aggregation, specifically a method of inhibiting platelet aggregation using an aptamer that binds to and inhibits the activity of a receptor, such as glycoprotein IIb/IIIa (gpIIb/IIIa). These patents also cover antidotes to antiplatelet agents and methods for reversing aptamer-induced platelet inhibition. Additionally, her inventions include von Willebrand Factor (VWF) inhibitors and related antidotes, along with methods for their application.

Career Highlights

Nanette Que-Gewirth is affiliated with Duke University, where she continues her research and innovation in the medical field. Her work is characterized by a commitment to advancing knowledge and developing practical solutions for health-related challenges.

Collaborations

She has collaborated with notable colleagues, including Bruce A. Sullenger and Shahid M. Nimjee, who share her dedication to innovation in medical science.

Conclusion

Nanette Que-Gewirth's contributions to the field of platelet inhibition exemplify her role as a leading inventor. Her innovative patents and collaborations highlight her commitment to advancing medical science and improving patient outcomes.